SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
GoodRx Holdings, Inc.
@GDRX_InsiderForm 4 Filing: Bruehlman Ronald E Acquires (Grant) shares of $GDRX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
GoodRx Holdings, Inc.
Ticker: $GDRX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-16
Shares: 73,434
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bruehlman Ronald E, holds the title of Director at GoodRx Holdings, Inc..
On 2026-06-16, the insider transacted 73,434 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bruehlman Ronald E (Director) was granted $0 of $GDRX
Post-Transaction Position: 207,352 shares
SEC Accession No: 0001809519-26-000125 (CIK: 1604076)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.